Top five ways to reduce cancer risk

submitted by: mdanderson

You can reduce your cancer risk by following these simple guidelines from Ernest Hawk, M.D., vice president of Cancer Prevention and Population Sciences at MD Anderson Cancer Center. Many diseases can be avoided by changing your lifestyle. Learn what you can reduce your risk for cancer.

Personalized treatment for ovarian cancer

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/personalized-treatment-for/id4318482... MD Anderson Cancer Center now has a more strategic approach to treating ovarian cancer which results in a 68% higher rate of removing the whole cancer tumor. Previously, all new ovarian cancer patients would undergo surgery to explore the extent of the disease and remove as much of it as possible. Under this new protocol, all patients undergo this procedure to determine if chemotherapy may...

Wilms’ tumor: childhood kidney cancer

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/wilms-tumor-childhood-kidney/id43184... Wilms’ tumor is a cancer that develops in the kidney and is the fifth most common cancer in children. Generally there are no symptoms and Wilms’ tumor is most likely discovered when a large mass is felt by a parent. Najat Daw, M.D., professor in Pediatrics at MD Anderson Cancer Center, discusses detection, treatment and research for Wilms’ tumor.

Prostate Cancer Moon Shot update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/prostate-cancer-moon-shot/id43184821... . The Prostate Cancer Moon Shot at MD Anderson Cancer Center focuses on: reducing overtreatment; combining therapies used in more advanced cases to treat the disease earlier; and developing new, targeted therapies (including immunotherapy) for patients who see little to no benefit from traditional treatment methods. Timothy Thompson, Ph.D., professor in Genitourinary Medical Oncology, discusses...

Lung Cancer Moon Shot update

submitted by: mdanderson
Lung cancer is being fought on three fronts at MD Anderson Cancer Center: prevention, early detection and treatment of advanced disease. John Heymach, M.D., Ph.D., professor in Thoracic/Head and Neck Medical Oncology at MD Anderson, talks about new developments in lung cancer research including advances in genetic mapping, molecular profiling, diagnostic imaging and lung cancer screening. With lung cancer being a part of the MD Anderson’s Moon Shots Program, we have a chance to make lung...

Improved chemotherapy administration reduces chance for medication errors

submitted by: mdanderson

MD Anderson Cancer Center is the first hospital in the United States to implement a new technology that will greatly improve chemotherapy quality control. Our main goal is patient safety. Kelley Reece, assistant manager in Pharmacy, explains how this software helps standardize the delivery of care across technicians and clinics. She also gives a behind the scenes look at how chemotherapy drugs are individually prepared for each unique patient.

Melanoma Moon Shot update 2014

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/melanoma-moon-shot-update/id43184821... . Cases of melanoma and deaths from this form of skin cancer are on the rise. MD Anderson is ideally suited to tackle this growing challenge because of our unparalleled resources and capabilities. Michael Davies, M.D., Ph.D., associate professor of Melanoma Medical Oncology at MD Anderson Cancer Center, discusses the recent advances made in the organization’s Melanoma Moon Shot program.

Chronic Lymphocytic Leukemia Moon Shot (CLL) update

submitted by: mdanderson

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

Best therapies for relapsed diffuse large b-cell lymphoma

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/best-therapies-for-relapsed/id431848... . When diffuse large b-cell lymphoma returns after the cancer patient is initially treated, it is called relapsed diffuse large b-cell lymphoma (DLBCL). If this happens, other therapies besides the standard R-CHOP (chemotherapy drugs cyclophosphamide, doxorubicin, vincristine, and prednisone) may be successful in fighting the disease. Jason Westin, M.D., assistant professor in Lymphoma/Myeloma...

Immunotherapy: unleashing immune system to attack cancer

submitted by: mdanderson
Cancer immunotherapy treats the immune system rather than the tumor. Jim Allison, Ph.D., professor in Immunology at MD Anderson Cancer Center, has developed an innovative approach that will open doors for treating all types of cancer. Padmanee Sharma, M.D., Ph.D., associate professor in Genitourinary Medical Oncology and Immunology, is lead scientist on immunotherapy clinical trials. Listen to Allison and Sharma discuss their collaboration on MD Anderson’s Moon Shots Program to develop...